1. Short title This Act may be cited as the Advancing Research for Chronic Pain Act of 2023 . 2. National Chronic Pain Information System Part P of title III of the Public Health Service Act ( 42 U.S.C. 280g et seq. ) is amended by adding at the end the following: 399V–8. Chronic pain research (a) In general The Secretary, acting through the Director of the Centers for Disease Control and Prevention in consultation with the Director of the National Center for Injury Prevention and Control and the Director of the National Center for Chronic Disease Prevention and Health Promotion, and in coordination with the NIH Helping to End Addiction Long-term Initiative and with other agencies as the Secretary determines appropriate, shall— (1) utilize available Federal research data to clarify the incidence and prevalence of chronic pain from any source, including injuries, operations, and diseases and conditions; (2) identify gaps in the available research data and collect deidentified population research data using medical claims and survey data to fill gaps in available research data, such as information concerning— (A) incidence and prevalence of specific pain conditions; (B) demographics and other information, such as age, race, ethnicity, gender, and geographic location; (C) the incidence and prevalence of known chronic pain conditions, as well as of diseases and conditions that include or lead to pain; (D) risk factors that may be associated with chronic pain conditions, such as genetic and environmental risk factors and other information, as appropriate; (E) diagnosis and progression markers; (F) both direct and indirect costs of illness; (G) the epidemiology of the conditions; (H) the detection, management, and treatment of the conditions; (I) the epidemiology, detection, management, and treatment of frequent secondary or co-occurring conditions, such as depressive, anxiety, and substance use disorders